Salmen, Anke

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2019 | 2018 | 2017 | 2016

2019

Graetz, Christiane; Gröger, Adriane; Luessi, Felix; Salmen, Anke; Zöller, Daniela; Schultz, Janine; Siller, Nelly; Fleischer, Vinzenz; Bellenberg, Barbara; Berthele, Achim; Biberacher, Viola; Havla, Joachim; Hecker, Michael; Hohlfeld, Reinhard; Infante-Duarte, Carmen; Kirschke, Jan S; Kümpfel, Tania; Linker, Ralf; Paul, Friedemann; Pfeuffer, Steffen; ... (2019). Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis. Multiple sclerosis journal, 25(5), pp. 661-668. Sage 10.1177/1352458518763541

Miclea, A.; Salmen, Anke; Zoehner, G.; Diem, Lara; Kamm, Christian P.; Chaloulos-Iakovidis, Panagiotis; Miclea, M.; Briner, Myriam Sandra; Kilidireas, K.; Stefanis, L.; Chan, Andrew; Evangelopoulos, Maria Eleptheria; Hoepner, Robert (2019). Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study. CNS neuroscience & therapeutics, 25(4), pp. 527-531. Blackwell Publishing 10.1111/cns.13083

Johnen, A.; Burkner, P. C.; Landmeyer, N. C.; Ambrosius, B.; Calabrese, P.; Motte, J.; Hessler, N.; Antony, G.; Konig, I. R.; Klotz, L.; Hoshi, M. M.; Aly, L.; Groppa, S.; Luessi, F.; Paul, F.; Tackenberg, B.; Bergh, F. T.; Kumpfel, T.; Tumani, H.; Stangel, M.; ... (2019). Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). Journal of neurology, 266(2), pp. 386-397. Springer-Medizin-Verlag 10.1007/s00415-018-9142-y

Barin, L.; Kaufmann, M.; Salmen, Anke; Kamm, Christian P.; Gobbi, C.; Kuhle, J.; Pot, C.; Chan, Andrew; Czaplinski, A.; Ajdacic-Gross, V.; Rodgers, S.; Kesselring, J.; Puhan, M. A.; von Wyl, V. (2019). Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study. Multiple Sclerosis and Related Disorders, 28, pp. 17-25. Elsevier 10.1016/j.msard.2018.11.033

Miclea, Andrei; Salmen, Anke; Wiest, Roland; Zoehner, Greta; Wagner, Franca; Hoepner, Andreas; Schrewe, Lisa; Evangelopoulos, Maria-Eleptheria; Kamber, Nicole; Chan, Andrew Hao-Kuang; Hoepner, Robert (2019). Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study. Therapeutic advances in neurological disorders, 12, p. 1756286419835652. Sage 10.1177/1756286419835652

Briner, Myriam; Bagnoud, Maud; Miclea, Andrei; Friedli, Christoph; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2019). Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age. Therapeutic advances in neurological disorders, 12, p. 1756286419843450. Sage 10.1177/1756286419843450

2018

Kaufmann, M.; Kuhle, J.; Puhan, M. A.; Kamm, Christian Philipp; Chan, Andrew; Salmen, Anke; Kesselring, J.; Calabrese, P.; Gobbi, C.; Pot, C.; Steinemann, N.; Rodgers, S.; von Wyl, V. (2018). Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland. Multiple sclerosis journal - experimental, translational and clinical, 4(4), p. 2055217318814562. Sage Publications 10.1177/2055217318814562

Salmen, Anke (2018). Clinical commentary on "Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab". Multiple sclerosis journal, 24(3), pp. 360-362. Sage 10.1177/1352458517717810

Rummel, Christian; Aschwanden, Fabian; McKinley, Richard; Wagner, Franca; Salmen, Anke; Chan, Andrew; Wiest, Roland (2018). A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease. Frontiers in neurology, 8, p. 727. Frontiers Media S.A. 10.3389/fneur.2017.00727

Thiel, S.; Leypoldt, F.; Röpke, L.; Wandinger, K.; Kümpfel, T.; Aktas, O.; von Bismarck, O.; Salmen, Anke; Ambrosius, B.; Ellrichmann, G.; Antony, G.; Dankowski, T.; Ziegler, A.; Stahmann, A.; Meyer, C.; Eichstädt, K.; Buckow, K.; Meißner, T.; Thibaut, J.; Khil, L.; ... (2018). Neuroimmunological Registries in Germany. Neurology international open, 02(01), E25-E39. Thieme 10.1055/s-0043-108830

von Bismarck, Olga; Dankowski, Theresa; Ambrosius, Björn; Hessler, Nicole; Antony, Gisela; Ziegler, Andreas; Hoshi, Muna-Miriam; Aly, Lilian; Luessi, Felix; Groppa, Sergiu; Klotz, Luisa; Meuth, Sven G.; Tackenberg, Björn; Stoppe, Muriel; Then Bergh, Florian; Tumani, Hayrettin; Kümpfel, Tania; Stangel, Martin; Heesen, Christoph; Wildemann, Brigitte; ... (2018). Treatment choices and neuropsychological symptoms of a large cohort of early MS. Neurology: Neuroimmunology and Neuroinflammation, 5(3), e446. Wolters Kluwer Health 10.1212/NXI.0000000000000446

Barin, Laura; Salmen, Anke; Disanto, Giulio; Babačić, Haris; Calabrese, Pasquale; Chan, Andrew; Kamm, Christian P.; Kesselring, Jürg; Kuhle, Jens; Gobbi, Claudio; Pot, Caroline; Puhan, Milo A.; von Wyl, Viktor (2018). The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most? Multiple Sclerosis and Related Disorders, 25, pp. 112-121. Elsevier 10.1016/j.msard.2018.07.013

Wagner, Franca; Grunder, Lorenz Nicolas; Hakim, Arsany; Kamber, Nicole; Horn, Michael; Müllner, Julia Nicole Maria; Hoepner, Robert; Wiest, Roland; Metz, Imke; Chan, Andrew; Salmen, Anke (2018). Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders. Frontiers in neurology, 9(782), p. 782. Frontiers Media S.A. 10.3389/fneur.2018.00782

2017

Hagström, Inga T; Schneider, Ruth; Bellenberg, Barbara; Salmen, Anke; Weiler, Florian; Köster, Odo; Gold, Ralf; Lukas, Carsten (2017). Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study. Journal of neurology, 264(7), pp. 1402-1412. Springer-Medizin-Verlag 10.1007/s00415-017-8537-5

Salmen, Anke; Chan, Andrew (2017). NMO-Spektrum-Erkrankungen (NMOSE). In: Berlit, P (ed.) Klinische Neurologie. Springer Reference Medizin (pp. 1-15). Berlin; Heidelberg: Springer 10.1007/978-3-662-44768-0_161-1

2016

Kinner, Markus; Hoepner, Robert; Klotz, Peter; Prehn, Christian; Faissner, Simon; Salmen, Anke; Linker, Ralf A; Gold, Ralf; Chan, Andrew (2016). Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis. CNS neuroscience & therapeutics, 22(12), pp. 1019-1022. Wiley 10.1111/cns.12652

Hoepner, Robert; Kolb, Eva M; Dahlhaus, Stefanie; Hellwig, Kerstin; Adams, Ortwin; Kleiter, Ingo; Salmen, Anke; Schneider, Ruth; Lukas, Carsten; Chan, Andrew; Berger, Joseph R; Gold, Ralf (2016). Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy. Multiple sclerosis journal, 23(6), pp. 830-835. Sage 10.1177/1352458516667241

Recke, A; Oei, A; Hübner, F; Fechner, K; Graf, J; Hagenah, J; May, C; Woitalla, D; Salmen, Anke; Zillikens, D; Gold, R; Schlumberger, W; Schmidt, E (2016). Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction. British journal of dermatology, 175(2), pp. 407-409. Wiley-Blackwell 10.1111/bjd.14538

Andlauer, Till F M; Buck, Dorothea; Antony, Gisela; Bayas, Antonios; Bechmann, Lukas; Berthele, Achim; Chan, Andrew; Gasperi, Christiane; Gold, Ralf; Graetz, Christiane; Haas, Jürgen; Hecker, Michael; Infante-Duarte, Carmen; Knop, Matthias; Kümpfel, Tania; Limmroth, Volker; Linker, Ralf A; Loleit, Verena; Luessi, Felix; Meuth, Sven G; ... (2016). Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Science Advances, 2(6), e1501678. American Association for the Advancement of Science 10.1126/sciadv.1501678

Klotz, L; Berthele, A; Brück, W; Chan, Andrew; Flachenecker, P; Gold, R; Haghikia, A; Hellwig, K; Hemmer, B; Hohlfeld, R; Korn, T; Kümpfel, T; Lang, M; Limmroth, V; Linker, R A; Meier, U; Meuth, S G; Paul, F; Salmen, Anke; Stangel, M; ... (2016). [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt, 87(6), pp. 645-659. Springer 10.1007/s00115-016-0077-1

Salmen, Anke; von Ahsen, N.; Trampe, A. K.; Hoepner, R.; Plavina, T.; Subramanyam, M.; Kuesters, G.; Gold, R.; Chan, Andrew (2016). Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy. Multiple sclerosis journal - experimental, translational and clinical, 2, p. 205521731663000. Sage Publications 10.1177/2055217316630008

Salmen, Anke; Linker, R; Gold, R (2016). "Oral Dimethyl Fumarate (BG-12; Tecfidera®) for Multiple Sclerosis.". In: Arnon, Ruth; Miller, Ariel (eds.) Translational Neuroimmunology in Multiple Sclerosis: From Disease Mechanisms to Clinical Applications. (pp. 271-283). Elsevier 10.1016/B978-0-12-801914-6.00022-2

Provide Feedback